Your browser doesn't support javascript.
loading
The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?
Damiani, G; Pacifico, A; Pelloni, F; Iorizzo, M.
Affiliation
  • Damiani G; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
  • Pacifico A; Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
  • Pelloni F; PhD Degree Program in Pharmacological Sciences, Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
  • Iorizzo M; Clinical Dermatology Department, IRCCS S. Gallicano Dermatological Institute, Rome, Italy.
J Eur Acad Dermatol Venereol ; 35(10): e645-e647, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34169578
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pemphigoid, Bullous / Pemphigus / COVID-19 Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Italia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pemphigoid, Bullous / Pemphigus / COVID-19 Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Italia Country of publication: Reino Unido